![David Reese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Reese
Chief Executive Officer at
KAI Pharmaceuticals, Inc.
Net worth: 18 M $ as of 31/08/2026
Profile
Founder of Translational Oncology Research International, Inc., David M. Reese is Executive Vice President-Research & Development at Amgen, Inc. Dr. Reese previously held the position of Director-Clinical Research at Breast Cancer International Research Group Ltd. and Director-Clinical Research at Translational Research In Oncology. He received an undergraduate degree from Harvard College and an undergraduate degree from The University of Cincinnati College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AMGEN INC. 0.01% | 07/05/2026 | 42,256 ( 0.01% ) | 18 M $ | 31/08/2026 |
David Reese active positions
| Companies | Position | Start |
|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | President | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Director/Board Member | - |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Chief Executive Officer | - |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | President | - |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Director/Board Member | 22/04/2023 |
Former positions of David Reese
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 30/06/2026 |
Translational Oncology Research International, Inc.
 Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Founder | 01/01/2005 |
Breast Cancer International Research Group Ltd.
 Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Corporate Officer/Principal | 01/01/2003 |
| CHEMOCENTRYX, INC. | Chief Executive Officer | - |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of David Reese
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Translational Research In Oncology
 Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Commercial Services |
Translational Oncology Research International, Inc.
Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Health Technology |
Breast Cancer International Research Group Ltd.
Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Cancer International Research Group (CIRG) is a not-for-profit academic research organization focused on oncology and is part of the TRIO group, which encompasses the Breast Cancer International Research Group and a clinical trial operations branch. The private company is based in Edmonton, Canada. CIRG offers clinical research services, managing studies from small dose-finding trials to large phase III registration trials. The organization supports clinical research across all phases of drug development, utilizing translational approaches based on the biology of diseases, and provides flexible services to meet various sponsor requirements. The Canadian company was founded by Alessandro Riva. | Commercial Services |
- Stock Market
- Insiders
- David Reese
